Frontiers in Endocrinology (Jan 2024)

Recent progress in metabolic reprogramming in gestational diabetes mellitus: a review

  • Ya-ping Xie,
  • Shu Lin,
  • Shu Lin,
  • Bao-yuan Xie,
  • Hui-fen Zhao

DOI
https://doi.org/10.3389/fendo.2023.1284160
Journal volume & issue
Vol. 14

Abstract

Read online

Gestational diabetes mellitus is a prevalent metabolic disease that can impact the normal course of pregnancy and delivery, leading to adverse outcomes for both mother and child. Its pathogenesis is complex and involves various factors, such as insulin resistance and β-cell dysfunction. Metabolic reprogramming, which involves mitochondrial oxidative phosphorylation and glycolysis, is crucial for maintaining human metabolic balance and is involved in the pathogenesis and progression of gestational diabetes mellitus. However, research on the link and metabolic pathways between metabolic reprogramming and gestational diabetes mellitus is limited. Therefore, we reviewed the relationship between metabolic reprogramming and gestational diabetes mellitus to provide new therapeutic strategies for maternal health during pregnancy and reduce the risk of developing gestational diabetes mellitus.

Keywords